Total number of consecutive study patients | 46 | |
---|---|---|
Age (median, interquartile range) | 70 (58-80) | |
Sex | Male | 27 (59 %) |
Female | 19 (41 %) | |
Tg blood levels (median, interquartile range) | Under TSH suppression | 5.35 μg/l (0,35-79,22) |
Under TSH stimulation | 31.4 μg/l (3,47-454,75) | |
Histopathology | Follicular | 16 (35 %) |
Papillary | 25 (54 %) | |
Poorly differentiated | 4 (9 %) | |
Anaplastic | 1 (2 %) | |
Stage of disease | I | 3 (6 %) |
II | 2 (4 %) | |
III | 5 (11 %) | |
Iva | 8 (18 %) | |
IVb | 2 (4 %) | |
IVc | 24 (53 %) | |
x | 2 (4 %) | |
Primary tumor | Ia | 2 (4 %) |
Ib | 4 (9 %) | |
2 | 8 (18 %) | |
3 | 16 (35 %) | |
4 | 12 (25 %) | |
x | 4 (9 %) | |
Regional lymph nodes | 0 | 17 (37 %) |
1a | 9 (20 %) | |
1b | 15 (33 %) | |
x | 5 (10 %) | |
Distant metastasis | 0 | 16 (35 %) |
1 | 23 (50 %) | |
x | 7 (15 %) |